Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frans M J Debruyne

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
BJU International|December 20, 2005
Design of clinical trials in advanced prostate cancer: avoiding the dead endsFrans M J Debruyne
Reviews in Urology|September 21, 2006
Gonadotropin-releasing hormone antagonist in the management of prostate cancerFrans M J Debruyne
European Urology|July 25, 2006
Medical management of BPH: the debate continuesFrans M J Debruyne
Urologic Oncology|February 22, 2025
Festschrift essay to celebrate Dr. Michael DrollerFrans M J Debruyne
The Canadian Journal of Urology|April 21, 2015
Legends in urologyFrans M J Debruyne
Nature Clinical Practice. Urology|December 7, 2006
Subspecialty certification in urology: a European perspectiveFrans M J Debruyne
Urology|March 12, 2004
Clinical and socioeconomic relevance of overactive bladderFrans M J Debruyne, John P F A Heesakkers
International Journal of Impotence Research|September 11, 2023
The post-finasteride syndrome: possible etiological mechanisms and symptomsHerman H J Leliefeld, Frans M J Debruyne, Yakov Reisman
Current Opinion in Urology|August 13, 2002
Important factors in the diagnosis and primary staging of testicular tumoursJ Roan Spermon, Frans M J Debruyne, J Alfred Witjes
European Urology|September 12, 2021
Reply to Bexultan Kazybay and Yingqiu Xie's Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024Herjan J T Coelingh Bennink, Jean-Michel Foidart, Frans M J Debruyne
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
BJU International|December 20, 2005
Design of clinical trials in advanced prostate cancer: avoiding the dead endsFrans M J Debruyne
Reviews in Urology|September 21, 2006
Gonadotropin-releasing hormone antagonist in the management of prostate cancerFrans M J Debruyne
European Urology|July 25, 2006
Medical management of BPH: the debate continuesFrans M J Debruyne
Urologic Oncology|February 22, 2025
Festschrift essay to celebrate Dr. Michael DrollerFrans M J Debruyne
The Canadian Journal of Urology|April 21, 2015
Legends in urologyFrans M J Debruyne
Nature Clinical Practice. Urology|December 7, 2006
Subspecialty certification in urology: a European perspectiveFrans M J Debruyne
Urology|March 12, 2004
Clinical and socioeconomic relevance of overactive bladderFrans M J Debruyne, John P F A Heesakkers
International Journal of Impotence Research|September 11, 2023
The post-finasteride syndrome: possible etiological mechanisms and symptomsHerman H J Leliefeld, Frans M J Debruyne, Yakov Reisman
Current Opinion in Urology|August 13, 2002
Important factors in the diagnosis and primary staging of testicular tumoursJ Roan Spermon, Frans M J Debruyne, J Alfred Witjes
European Urology|September 12, 2021
Reply to Bexultan Kazybay and Yingqiu Xie's Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024Herjan J T Coelingh Bennink, Jean-Michel Foidart, Frans M J Debruyne
Pageof 4